Cas:56240-89-2 4-amino-3-heptyl-1H-1,2,4-triazole-5-thione manufacturer & supplier

We serve Chemical Name:4-amino-3-heptyl-1H-1,2,4-triazole-5-thione CAS:56240-89-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-amino-3-heptyl-1H-1,2,4-triazole-5-thione

Chemical Name:4-amino-3-heptyl-1H-1,2,4-triazole-5-thione
CAS.NO:56240-89-2
Synonyms:4-amino-5-heptyl-4H-1,2,4-triazole-3-thiol;4-Amino-3-n-heptyl-5-mercapto-s-triazole;4-AMINO-5-HEPTYL-3-MERCAPTO-1,2,4-TRIAZOLE
Molecular Formula:C9H18N4S
Molecular Weight:214.33100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:378.8ºC at 760 mmHg
Density:1.23g/cm3
Index of Refraction:1.614
PSA:95.53000
Exact Mass:214.12500
LogP:2.37470

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-amino-5-heptyl-4H-1,2,4-triazole-3-thiol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-AMINO-5-HEPTYL-3-MERCAPTO-1,2,4-TRIAZOLE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-amino-5-heptyl-4H-1,2,4-triazole-3-thiol Use and application,4-AMINO-5-HEPTYL-3-MERCAPTO-1,2,4-TRIAZOLE technical grade,usp/ep/jp grade.


Related News: Hong Kong confirmed its 14th coronavirus case late Saturday. The patient, an 80-year-old man, had traveled for a few hours to mainland China in early January, and later spent several days on a cruise ship in Japan with more than 3,000 passengers and employees. 4-amino-3-heptyl-1H-1,2,4-triazole-5-thione manufacturer Some of Amanpour’s counterparts also offered well-wishes on Monday. 4-amino-3-heptyl-1H-1,2,4-triazole-5-thione supplier Some of Amanpour’s counterparts also offered well-wishes on Monday. 4-amino-3-heptyl-1H-1,2,4-triazole-5-thione vendor Some of Amanpour’s counterparts also offered well-wishes on Monday. 4-amino-3-heptyl-1H-1,2,4-triazole-5-thione factory Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.